These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature. Boogaard R; de Jongste JC; Merkus PJ Pediatr Pulmonol; 2007 Nov; 42(11):989-1001. PubMed ID: 17902149 [TBL] [Abstract][Full Text] [Related]
6. [Spasmolytic and mucolytic agents in the treatment of acute dyspneic pneumopathies in children]. Manicatide ET; Căpraru H Pediatria (Bucur); 1973; 22(4):357-60. PubMed ID: 4761443 [No Abstract] [Full Text] [Related]
7. The pharmacologic approach to airway clearance: mucoactive agents. Rubin BK Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570 [TBL] [Abstract][Full Text] [Related]
8. [Bronchial mucus modifiers, antioxidants and antiproteases]. Polu JM; Chabot F; Wallaert B Rev Mal Respir; 1993; 10(2):87-100. PubMed ID: 8502804 [No Abstract] [Full Text] [Related]
9. Aerosol Medications for Treatment of Mucus Clearance Disorders. Rubin BK Respir Care; 2015 Jun; 60(6):825-9; discussion 830-32. PubMed ID: 26070577 [TBL] [Abstract][Full Text] [Related]
10. Methods for clinical assessment of expectorants: a critical review. Lurie A; Mestiri M; Huchon G; Marsac J; Lockhart A; Strauch G; Bergogne-Berezin E; Bignon J; Carbon C; Chwalow J Int J Clin Pharmacol Res; 1992; 12(1):47-52. PubMed ID: 1526698 [TBL] [Abstract][Full Text] [Related]
11. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance]. Miyata T Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863 [TBL] [Abstract][Full Text] [Related]
13. Respiratory mucociliary clearance in the horse in health and disease, and its pharmaceutical modification. Dixon PM Vet Rec; 1992 Sep; 131(11):229-35. PubMed ID: 1441112 [TBL] [Abstract][Full Text] [Related]
15. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis. Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992 [TBL] [Abstract][Full Text] [Related]
16. Evaluating the efficacy of mucoactive aerosol therapy. Fuloria M; Rubin BK Respir Care; 2000 Jul; 45(7):868-73. PubMed ID: 10926385 [TBL] [Abstract][Full Text] [Related]
17. [Mucociliary clearance function and medicamentous modification]. Konrad F Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Sep; 31(7):404-8. PubMed ID: 8991466 [TBL] [Abstract][Full Text] [Related]
18. Mucus-controlling agents: past and present. King M; Rubin BK Respir Care Clin N Am; 1999 Dec; 5(4):575-94. PubMed ID: 10565882 [TBL] [Abstract][Full Text] [Related]
19. [Expectorants: an expensive, mostly ineffective therapy of chronic cough]. Medici TC; Züllig A; Schmid A Schweiz Rundsch Med Prax; 1988 Sep; 77(39):1048-54. PubMed ID: 3051267 [No Abstract] [Full Text] [Related]
20. [Experiences with the new mucolytic agent Bisolvon in general practice, with special reference to asthmoid states]. Stäubli C Praxis; 1966 Jul; 55(30):850-3. PubMed ID: 5953646 [No Abstract] [Full Text] [Related] [Next] [New Search]